Client Alerts & Insights
ODH Releases Bed Need Information for CON; Discusses LTACH Average Day Maximum
April 1, 2010
The Ohio Department of Health (ODH) recently released the results of the bed need formula on their website. Details include information on inter-county bed transfers; a map showing which counties can donate beds and those that can receive beds; a spreadsheet with the data used to determine bed need; and a spreadsheet dividing the counties into those that need beds, can donate beds, and no beds can be moved in or out of. Hamilton and Cuyahoga counties are the most “over bedded” according to the formula, while Franklin, Delaware and Montgomery counties show the greatest need. ODH will accept certificate of need (CON) applications for inter-county transfers of long-term beds from July 1, 2010 to July 30, 2010. ODH also discussed extending the maximum average length of stay for long term acute care hospitals (LTACH) with interested parties this week. LTACH representatives want to remove the cap while skilled nursing facility (SNF) representatives prefer a cap to avoid LTACHs from treating the same consumers as a high acuity SNF. There was agreement to extend the cap from 30 days to 45 days.
Latest News
Supreme Court Clarifies Judicial Estoppel Standard in Bankruptcy Nondisclosure Cases
The U.S. Supreme Court rejected a rigid rule that often blocked debtors from pursuing claims they failed to disclose in bankruptcy. Courts must now look at the full circumstances before deciding whether an omission was intentional or an honest mistake.
Federal Court Hands Major Win to Tissue Product Manufacturers – FDA’s HCT/P Classification Decision for Umbilical Cord–Derived Product CORDGRAFT Rejected
On March 18, 2026, Chief Judge Brian C. Wimes of the U.S. District Court for the Western District of Missouri issued a significant decision overturning the U.S. Food and Drug Administration’s (“FDA”) classification of Vitti Labs’ umbilical cord–derived product, CORDGRAFT.
Science-Backed But Not FDA-Approved: New Lawsuit Challenges FDA’s Rejection of 114 Health-Related Advertising Claims
A new lawsuit challenges the FDA’s rejection of 114 health-related advertising claims for supplements, arguing that the agency’s narrow interpretation of what counts as an “authoritative statement” unfairly blocks science-backed—but not FDA-approved—claims from appearing on product labels.
When ChatGPT Lies: What the First Wave of AI Defamation Cases Means for Plaintiffs
The common argument made by plaintiffs that differences in alleged misrepresentations are transcended by the center of the gravity of the alleged fraud should not be addressed through the typical approach of just comparing the level of variance of the representations in the case at issue with that in the relevant precedent.